Companion diagnostics (CDx) in precision medicine:

There is a new trend in anti-cancer therapeutics development: a targeted therapy and precision medicine that targets a subgroup of patients with specific biomarkers. An in vitro diagnostic (IVD) assay is required to identify a subgroup of cancer patients who would benefit from the targeted therapy,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Kim, Il-Jin (HerausgeberIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Singapore Pan Stanford Publishing 2019
Schlagworte:
Online-Zugang:Volltext
Zusammenfassung:There is a new trend in anti-cancer therapeutics development: a targeted therapy and precision medicine that targets a subgroup of patients with specific biomarkers. An in vitro diagnostic (IVD) assay is required to identify a subgroup of cancer patients who would benefit from the targeted therapy, or not likely benefit, or have a high risk of side effects from the specific drug treatment. This IVD or medical device is called a companion diagnostic (CDx) assay. It is key to have a robust CDx assay or device for the success of targeted therapy and precision medicine. This book covers the technical, historical, clinical, and regulatory aspects of CDx in precision medicine. Clearly, more and more newly developed oncology drugs will require accompanying CDx assays, and this book, with chapters contributed by renowned oncologists, provides a comprehensive foundation for the knowledge and application of CDx for precision medicine
Beschreibung:OCLC-licensed vendor bibliographic record
Beschreibung:1 online resource
ISBN:9780415000383
0415000386
9780429275906
0429275900
9781000000382
1000000389
9781000013740
100001374X
9781000007213
1000007219

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen